Lilly and Novo whipsaw Wall Street with split in obesity outlook

Lilly and Novo whipsaw Wall Street with split in obesity outlook


Within 19 hours, weight loss drugmakers Novo Nordisk A/S and Eli Lilly & Co. offered divergent views on where business is headed. Read on

Author: Bloomberg News


Published at: 2026-02-04 21:49:21

Still want to read the full version? Full article